CIK 0001515673
- Large accelerated filer
Ultragenyx Pharmaceutical Inc.
Sign in to watch- Ticker
- RARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272546083
- Phone
- +1 415-483-8800
- Business address
- 60 LEVERONI COURT, NOVATO, CA, 94949
- 4 Open-market sale President & CEO sold 30,000 shares at $136.90 ($4,107,000)
- 4 Open-market sale Director sold 800,000 shares at an average $100.81 ($80,650,635)
- 4 Open-market sale President & CEO sold 30,000 shares at $96.82 ($2,904,600)
- 4 Open-market sale EVP and General Counsel sold 9,903 shares at $100.12 ($991,488)
- 4 Open-market sale EVP and General Counsel sold 97 shares at $100.00 ($9,700)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes President & CEO gave up 852 shares (to pay taxes)
- 4 Open-market sale EVP and Chief Medical Officer sold 262 shares at $88.00 ($23,056)
- 4 Open-market sale EVP and General Counsel sold 325 shares at $88.00 ($28,600)
- 4 Open-market sale CBO & EVP sold 262 shares at $87.98 ($23,051)
- 4 Open-market sale EVP & Chief Commercial Officer sold 220 shares at $88.00 ($19,360)
- 4 Open-market sale Pinion John Richard sold 262 shares at $88.00 ($23,056)
- 4 Open-market sale EVP & Chief Tech Ops Officer sold 262 shares at $88.00 ($23,056)
- 4 Open-market sale SVP, Controller and PAO sold 146 shares at $87.98 ($12,845)
- 4 Open-market sale EVP, Finance sold 375 shares at $87.99 ($32,996)
- 4 Open-market sale Pinion John Richard sold 2,780 shares at $94.47 ($262,627)
- 4 Open-market sale EVP and General Counsel sold 10,000 shares at $95.00 ($950,000)
- 4 Grant or award CFO & Executive Vice President acquired 40,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale EVP and General Counsel sold 10,000 shares at $90.00 ($900,000)
Page 12 of 32 · 627 filings